CJC-1295/Ipamorelin
aka CJC-1295 (no DAC) + Ipamorelin blend
Mechanism
A grey-market pre-mixed blend of CJC-1295 (no DAC / Modified GRF 1-29), a GHRH analog, and Ipamorelin, a selective ghrelin-receptor agonist. The blend itself is NOT clinically validated — no controlled human trial has tested this specific combination. The pharmacological rationale (GHRH + GHRP synergy for pulsatile GH amplification) is inferred from studies of other GHRH/GHRP pairs.
Identification
| Typical dose | 100–300 mcg of each component (CJC-1295 no DAC + Ipamorelin) per injection, 1–2x daily subcutaneous, typically on empty stomach |
|---|---|
| Half-life | CJC-1295 (no DAC): ~30 minutes; Ipamorelin: ~2 hours |
Vendors selling CJC-1295/Ipamorelin
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Peptide Partners | 40 mg | $220.00 | — | 99 |
| Moglabs | 5 mg | $58.00 | — | 96 |
| Crush Research | 10 mg | $43.00 | — | 95 |
| Orbitrex Peptides | — | $74.99 | — | 95 |
| Peptide Tech | — | $44.99 | — | 94 |
| Amino Club | 10 mg | $59.99 | — | 93 |
| Skye Peptides | — | $59.00 | — | 90 |
| Peptide Plugs | 10 mg | $50.00 | — | 89 |
| Qihang Peptide | — | — | — | 87 |
| Peptidegurus | 10 mg | — | — | 84 |
| Cocer Peptides | — | $175.00 | — | 82 |
| Cocer Peptides | — | $260.00 | — | 82 |
| Blank Peptides | 10 mg | $85.00 | — | 81 |
| Crystal Peptides | — | $64.99 | — | 66 |
| Mandy | 10 mg | $78.00 | — | 43 |
| MJT peptides | 10 mg | $119.00 | — | 39 |
| HK Peptide Ltd (hk peptides) | — | — | — | 37 |
| Apollo Peptide Sciences | — | — | — | — |
| Cernum Biosciences | — | $84.99 | — | — |
| NG Peptide | — | $40.00 | — | — |
| Ruo Bio | — | $56.00 | — | — |
Research
Background Injectable peptides are increasingly promoted for musculoskeletal recovery, tissue repair, and performance enhancements; however, clinical adoption has outpaced high-quality evidence and regulatory consensus.
source →Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
source →Background Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients.
source →Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.
source →